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OBJECTIVES The study compared the prognostic significance of myocardial perfusion single-photon
emission computed tomography (SPECT) (MPS) in patients early and late after coronary
artery bypass graft surgery (CABG).
BACKGROUND The long-term effectiveness of CABG is limited by graft stenosis. The greatest incidence of
graft occlusion occurs between five and eight years after surgery. However, little is known
regarding the appropriate time to stress patients post-CABG with respect to risk stratification.
METHODS We identified 1,765 patients, who underwent MPS 7.1 6 5.0 years post-CABG. All patients
underwent rest Tl-201/stress Tc-99m sestamibi MPS and were followed up $1 year after
testing. Patients with early CABG or PTCA (,60 days after MPS) were censored. The
prognostic population consisted of 1,544 patients. A semiquantitative visual analysis employ-
ing a 20-segment model was used to define summed stress score (SSS), summed rest score
(SRS), summed difference score (SDS), and the number of nonreversible segments (NRS).
RESULTS During follow-up, 53 cardiac deaths (CD) occurred. There was a significant increase in
annual CD rates as a function of SSS. A multivariate analysis identified age, ischemia (SDS),
and infarct size (NRS) as independent predictors of CD. Nuclear variables added incremental
value to prescan information. The annual CD rate was relatively low (1.3%) in patients #5
years post-CABG. In this subgroup only age and infarct size (NRS) were predictive of CD.
CONCLUSION MPS is strongly predictive of subsequent CD in post-CABG patients and adds incremental
value over clinical and treadmill test information. Our data suggest that symptomatic patients
#5 years and all patients .5 years post-CABG may benefit from testing. (J Am Coll Cardiol
2001;37:144–52) © 2001 by the American College of Cardiology
Myocardial perfusion SPECT (single-photon emission
computed tomography) (MPS) has been shown to be an
effective method for risk-stratification and guide for referral
to catheterization (1–3) in general coronary artery disease
(CAD) populations as well as in patients late (.5 years)
post-CABG (coronary artery bypass graft surgery) (4).
However, little is known regarding the value of MPS in risk
stratification or management of patients early (#5 years)
compared to late (.5 years) post-CABG.
In 1996, an estimated 598,000 CABG procedures were
reported in the U.S. (5). The long-term effectiveness of this
now common procedure is limited by graft stenosis and by
progression of disease in native vessels. Saphenous vein graft
occlusion rates have been reported to range from 41% to
50% at 10 years post-CABG (6–8). Fitzgibbon et al. (7)
observed in 222 patients that the greatest incidence of graft
occlusions and of severe graft atherosclerosis occurred in the
time between 5 and 7.5 years post-CABG surgery. Grondin
et al. (8) reported an occlusion rate of 12% to 20% in the
first year post-CABG, 2% to 4% annual rates for the next
four or five years, and approximately 50% at 10 years. The
time interval between 5 and 10 years after surgery also
corresponds to the period when severe symptoms most often
recur. However, the new development or recurrence of chest
pain is not useful for detecting graft occlusion, with a
reported sensitivity of 60% and a specificity of 20% (9).
Based on these findings we have chosen the cutoff of five
years for comparing two different groups (early and late)
post-CABG. The goals of the present retrospective study
were threefold: 1) to define the incremental prognostic value
of MPS for the prediction of cardiac death (CD) in patients
who underwent CABG, either # or .5 years before nuclear
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testing; 2) to define the ability of nuclear testing to risk-
stratify these patients; and 3) to determine the impact of
nuclear testing on referral to early catheterization.
METHODS
Study population. We identified 1,765 consecutive
CABG patients (excluding patients with significant valvular
heart disease or nonischemic cardiomyopathies) for rest
Tl-201/Tc-99m sestamibi SPECT in our laboratory be-
tween 1/17/91 and 2/4/97. Of these, 58 (3.3%) were lost to
follow-up. A total of 163 patients who underwent early
revascularization (percutaneous transluminal coronary an-
gioplasty, PTCA; or redo-CABG ,60 days after nuclear
testing) (10,11) were censored from the prognostic analysis
of this study. The final prognostic population was 1,544
patients, of whom 1,015 (65.7%) patients underwent exer-
cise and 529 (34.3%) adenosine SPECT.
Rest/stress myocardial perfusion SPECT protocol. All
patients underwent rest Tl-201/stress Tc-99m sestamibi
MPS as previously described (12). Initially, Tl-201 (2.5 to
4 mCi) was administered intravenously at rest, with the dose
varying by weight. Rest Tl-201 SPECT was performed
10 min after the tracer injection. For the patients undergo-
ing exercise stress, a symptom-limited exercise test was
performed, using standard protocols with a 12-lead electro-
cardiogram (ECG) recording each minute of exercise and
continuous monitoring of leads aVF, V1 and V5. Whenever
possible, beta-blocking medications, as well as negative
chronotropic calcium antagonists, were withheld for 48 h,
and long-acting nitrates were withheld for 6 h before the
exercise testing. End points of exercise testing were physical
exhaustion, severe angina, sustained ventricular arrhythmia
or exertional hypotension. At near-maximal exercise, a
20–35-mCi dose of Tc-99m sestamibi was injected (actual
dose varied with patient weight) and exercise was continued
for an additional minute after injection. For the adenosine
stress test, patients were instructed not to consume products
containing caffeine for 24 h before the test. After rest
Tl-201 SPECT, adenosine was infused (140 mg/kg/min for
6 min) for pharmacologic stress. Tc-99m sestamibi was
injected at the end of the 3rd min of infusion, and SPECT
was performed approximately 1 h later. Twenty-four hour
Tl-201 redistribution imaging was performed when fixed
defects were present, whenever possible.
For both types of stress, blood pressure was measured and
recorded at rest, at the end of each stress stage, and at peak
stress. Maximal degree of ST-segment change at 80 ms after
the J-point of the ECG was measured and assessed as
horizontal, downsloping or upsloping. The ECG response
to testing was categorized as either nonischemic (no signif-
icant ECG changes), ischemic (.1 mm horizontal or
downsloping or 1.5 mm upsloping ST-segment elevation or
depression except in leads with significant Q-waves or in
lead aVR), equivocal (borderline ECG changes), or nondi-
agnostic (exercise-induced ECG changes uninterpretable
because of digoxin use, paced rhythm, bundle branch block).
In 703 patients with interpretable stress ECG, the Duke
treadmill score was calculated and defined as low risk (.4);
moderate risk (210 to 14); or high risk (,210) (13). In
86% of patients the standard Bruce protocol was utilized,
and the Duke treadmill score was defined as:
Exercise duration 2 ~5 3 ST-max! 2 ~4 3 angina index!.
In 14% of patients a modified Bruce protocol was used, here
when the exercise duration was $4.5 min the exercise
duration was modified by subtracting 3 min.
SPECT acquisition protocol. The SPECT imaging was
performed as previously described (12). The SPECT studies
were performed using a circular or elliptical 180° acquisition
for 60 to 64 projections at 20 to 25 s per projection. During
imaging, two energy windows were used for Tl-201, includ-
ing a 30% window centered on the 68 to 80 keV peak and
a 10% window centered on the 167-keV peak. For Tc-99m
sestamibi SPECT, a 15% window centered on the 140-keV
peak was used. No attenuation or scatter correction was
used. All images were subject to quality control measures, as
previously described (12).
Image interpretation. Semiquantitative visual interpreta-
tion was performed using a 20-segment model as previously
described (1). Each segment was scored using a 5-point
scoring system (0 5 normal, 1 5 equivocal, 2 5 moderate,
3 5 severe reduction of radioisotope uptake, and 4 5
apparent absence of detectable tracer uptake in a segment).
A summed stress score (SSS) was obtained by adding the
scores of the 20 segments of the stress sestamibi images
(12). A summed rest score (SRS) was obtained similarly by
adding the scores of the 20 segments on the rest images.
Subsequently, to assess the defect reversibility, a summed
difference score (SDS) was calculated by subtracting the
SRS from the SSS. As per our previous work, SSS ,4 was
considered normal; 4 to 8, mildly abnormal; .8 moderately
to severely abnormal (2). Similarly, for the degree of
reversibility, SDS ,2 was considered nonischemic; between
2 to 4 mildly ischemic; and .4 moderately to severely
ischemic. The number of nonreversible segments (NRS)
(stress/rest score combinations of 4/4, 4/3, 3/3, 3/2, or 2/2)
was used as a surrogate marker of infarct size and left
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CAD 5 coronary artery disease
CD 5 cardiac death
LVEF 5 left ventricular ejection fraction
MPS 5 myocardial perfusion SPECT
NRS 5 nonreversible segments
PTCA 5 percutaneous transluminal coronary
angioplasty
SDS 5 summed difference score
SPECT 5 single-photon emission computed
tomography
SRS 5 summed rest score
SSS 5 summed stress score
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ventricular function, (with each one unit of NRS represent-
ing approximately 5% of the myocardium) since left ven-
tricular ejection fraction (LVEF) data from gated SPECT
was not available in the entire population. We choose to use
NRS because it is more closely related to the extent of
infarcted myocardium. When available, the late-
redistribution Tl-201 scores were used in place of rest scores
for calculation of SRS, SDS and NRS.
An annual event rate ,1% was considered as low risk, 1%
to 5% as intermediate, and .5% as high risk (14).
Patient follow-up. The follow-up was performed by
scripted telephone interviews by individuals blinded to the
patient’s test results. All patients were followed for at least
one year for the outcome of CD and early catheterization.
The mean follow-up time was 686 6 194 days. Cardiac
death was confirmed by review of death certificate and
hospital chart or physician’s records. Early catheterization
was defined by catheterization performed within 60 days
after the nuclear testing (2).
Prescan likelihood of ischemia. For purposes of analyzing
patients in different risk subsets we used analysis of the
prescan likelihood of ischemia as an aggregate descriptor of
proven prognostic importance based on Bayesian analysis of
patient data and calculated by CADENZA (15). For
patients undergoing pharmacologic stress, historical infor-
mation alone was considered (age, gender, presenting symp-
toms, resting blood pressure, smoking history, cholesterol,
glucose intolerance, and resting ECG); whereas for patients
undergoing exercise stress, the prescan likelihood of isch-
emia also included exercise test information (exercise pro-
tocol, exercise duration, metabolic equivalents [METs]
achieved, maximum heart rate, maximum blood pressure,
exertional hypotension, exercise-induced symptoms, ST-
segment change and slope). For purposes of a subanalysis,
assessing whether symptoms affected outcomes, we used the
patient’s symptoms at the time of testing. For this purpose,
patients with typical anginal chest pain, atypical anginal
chest pain or shortness of breath were considered symptom-
atic, whereas patients with nonanginal chest pain or no
symptoms were considered asymptomatic.
Statistical analysis. Comparisons between patient groups
were performed using the Student t-test for continuous
variables and a chi-square test for the categorical variables.
All continuous variables are described as a mean 6 SD. A
p value ,0.05 was considered statistically significant.
Because NRS was used as a surrogate marker for LVEF
we compared post-stress EF (16) and NRS by linear
regression in the 235 patients who underwent gated
SPECT.
Survival analyses were performed to investigate factors
that influence time-to-event (survival time), which was
defined from the index nuclear testing to CD. Because the
nuclear parameters were not normally distributed, and the
link function between the nuclear parameters and the
distribution of time-to-event can be very general, nonpara-
metric Cox proportional hazards survival models were used
to explore appropriate regression functions or transforma-
tions of the nuclear parameters. Then, a conventional Cox
proportional hazards survival model was used to identify
factors that are independently associated with CD (17).
Because the proportionality assumption for the Cox propor-
tional hazards survival model requires that the ratio of
hazard rates for different levels of an independent variable
must be constant, and patients who underwent exercise
stress were different from those who underwent pharmaco-
logic stress with respect to the hazard of an event, a stratified
Cox proportional hazards survival model was used. Stress
type was treated as the stratification variable. To investigate
the prognostic value of nuclear variables (SSS, SDS, NRS),
age, gender, time elapsed between CABG and nuclear
testing, prior myocardial infarction (MI), prescan likelihood
of ischemia, and symptoms were included as covariates in
the initial Cox model. Variables that were not significant
were eliminated from the initial model in a backward
manner, yielding a final model. The final model includes
only variables that were independently associated with CD.
The incremental value of nuclear testing was evaluated by
calculating the global x2 after having added the nuclear
variables to the prescan information. All multivariate anal-
yses were done using the SAS 6.12 statistical package.
RESULTS
Study population. The baseline characteristics of patients
undergoing exercise and adenosine stress are shown in Table
1. The former were younger, more likely to be men, were
less symptomatic, had a lower prescan likelihood of isch-
emia, and lower SSS, SRS and NRS than the latter.
Mean left ventricular EF in the 235 patients (14%) who
underwent gated SPECT was 49.1 6 15.2. There was an
inverse correlation between the EF and the NRS (y 5 55.3
to 3.1 x, r 5 0.59). Using this equation, an NRS of 4 was
roughly equivalent to an EF of 43%. Since Sharir et al. (18)
have shown that an LVEF ,45% to be the threshold below
which there is a significant increase risk of CD, we used this
value when developing the follow-up strategy described
below.
Table 1. Characteristics of Patients Who Underwent Exercise/
Pharmacologic Stress
Exercise
(n 5 1,015)
Adenosine
(n 5 529)
p
Value
Age (yrs) 67.7 6 10.1 73.2 6 9.3 , 0.0001
Gender (female) (%) 167 (16) 147 (28) , 0.0001
Symptoms (%) 493 (49) 327 (62) , 0.0001
Prescan likelihood 0.41 6 0.37 0.5 6 0.33 , 0.0001
SSS 11.7 6 10.3 14.4 6 10.2 , 0.0001
SDS 6.7 6 7.0 7.4 6 7.0 NS
SRS 4.7 6 7.8 6.8 6 8.9 , 0.0001
NRS 1.8 6 2.7 2.5 6 3.1 , 0.0001
NRS 5 number of nonreversible segments; Prescan likelihood 5 prescan likelihood
of ischemia; SDS 5 summed difference score; SRS 5 summed rest score; SSS 5
summed stress score.
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Outcome events. During follow-up, 53 CDs occurred.
Sixteen CDs (2.5%) occurred in 628 patients studied #5
years post-CABG and 37 (4.0%) CDs in 916 patients
studied .5 years post-CABG (p 5 0.11). Symptoms
contributed no prognostic value (Fig. 1). Patients who
suffered CD were significantly older, were more commonly
referred for pharmacologic stress, had a more remote sur-
gery and had significantly higher SSS, SRS and NRS (Table
2). Fifty-seven patients had an early (,60 days postnuclear)
redo-CABG and 66 patients had late redo-CABG. Their
annual CD rate was 2.7% and 2.4%, respectively. Of note, in
patients #5 years post-CABG undergoing repeat surgery
no CDs occurred. In patients .5 years post-CABG, CDs
occurred principally in patients with moderately to severely
abnormal scan results.
Relationship between SPECT result and outcomes. Pa-
tients with perfusion defects were more likely to die (2.1%
vs. 0.4% per year, p 5 0.004). The annual CD rates
increased significantly as a function of SSS in patients #
and .5 years post-CABG surgery (Fig. 2).
Early catheterization rates increased significantly as a
function of SSS (Fig. 3), p , 0.0001.
Multivariate analysis. Age, ischemia (SDS), and infarct
size (NRS) were independent predictors of CD with respect
to the whole study population (Table 3). In patients #5
years post-CABG, age and infarct size (NRS) were inde-
pendent predictors of CD. In patients .5 years post-
CABG, infarct size (NRS) and ischemia (SDS) were
independent predictors of CD.
Incremental value of nuclear testing. A significant in-
crease in global chi-square occurred with respect to CD
after adding nuclear data (SSS, SDS, NRS) to prescan
information and adjusting for the type of stress performed
(Fig. 4). For the treadmill group, a significant increases in
global chi-square (p , 0.05) occurred, with respect to CD,
Figure 1. Annual cardiac death (CD) rates as a function of time and symptoms (n 5 1544). p 5 NS for all comparisons.
Table 2. Patient Characteristics With or Without CD
(n 5 1,544)
CD
(n 5 53)
No CD
(n 5 1,491)
p
Value
Gender (female) (%) 13 (25) 301 (20) NS
Age (yrs) 73.8 6 8.8 69.4 6 10.2 0.002
MI before CABG (%) 10 (19) 370 (25) NS
MI between CABG and
SPECT (%)
15 (28) 366 (25) NS
PTCA before CABG (%) 1 (2) 128 (9) NS
PTCA between CABG and
SPECT (%)
7 (13) 221 (15) NS
Time CABG-SPECT (d) 2969 6 1950 2484 6 1778 0.05
Symptoms (%) 31 (58) 789 (53) NS
Prescan likelihood 0.45 6 0.34 0.44 6 0.36 NS
Adenosine stress test (%) 32 (60) 497 (33) , 0.001
SSS 19.2 6 9.4 12.4 6 10.3 , 0.001
SDS 8.0 6 7.7 6.9 6 7.0 NS
SRS 10.8 6 9.4 5.2 6 8.2 , 0.001
NRS 4.0 6 3.2 1.9 6 2.8 , 0.001
CABG 5 coronary artery bypass grafting; CD 5 cardiac death; MI 5 myocardial
infarction; NRS 5 number of nonreversible segments; Prescan likelihood 5 prescan
likelihood of ischemia; SDS 5 summed difference score; SRS 5 summed rest score;
SSS 5 summed stress score; Time CABG-SPECT 5 time between CABG and
nuclear testing.
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after first adding the Duke treadmill score in a first step and
then nuclear data in a second step (Fig. 5).
Optimized strategy for post-CABG risk assessment. An
optimized strategy for risk stratification based on this
population was developed, in which only patients with an
annual CD rate of $1% would be referred for catheteriza-
tion (Fig. 6).
DISCUSSION
Patients with previous CABG represent a substantial CAD
population. Risk stratification for subsequent CD in these
patients has clinical significance, because repeat CABG
could reduce the risk of death in high-risk cohorts. Our
results show a strong relationship between nuclear variables
and CD in patients, both # and .5 years post-CABG. The
number of nonreversible segments (NRS, a surrogate
marker of infarct size and LVEF) was the strongest predic-
tor of CD. By NRS, patients with CD had, on average,
twice the amount of infarcted myocardium compared to
patients without CD. In general, early catheterization rates
paralleled the risk of CD.
Risk stratification post-CABG. Patients undergoing
pharmacologic stress were at higher risk for CD. Therefore,
type of stress was used as stratification variable.
Nuclear testing added incremental prognostic value to
prescan information. The MPS variables for infarct size and
ischemia were predictors of CD in the whole patient
population and in patients .5 years post-CABG. In pa-
tients #5 years post-CABG and in treadmill patients,
infarct size was the only nuclear variable predictive of CD.
Although exercise testing without imaging has been
evaluated (19–21), these studies have generally shown little
prognostic value in post-CABG patients. In contrast, sev-
eral studies have shown that after evaluation of treadmill
and exercise data, MPS provides incremental prognostic
information for patients post-CABG (22,23). Palmas et al.
(4) demonstrated in 294 patients $5 years post-CABG that
the Tl-201 summed reversibility score and the presence of
increased lung uptake of Tl-201 added significant prognos-
tic information to a clinical model. Nallamothu et al. (24)
reported similar incremental information, even when coro-
nary angiographic variables were taken into account. In 250
patients, the extent of the Tl-201 perfusion abnormality,
Figure 2. Annual cardiac death (CD) rates as a function of SSS in patients #5 and .5 years post-CABG (n 5 1,544). *Statistically significant increase
as a function of SSS (p 5 0.049, 0.005 for #5 and .5 years, respectively. CABG 5 coronary artery bypass graft surgery; SSS 5 summed stress score.
Table 3. Independent Predictors of Cardiac Death
Whole
Population
(n 5 1,544)
p Value
Patients <5 years
post-CABG
(n 5 628)
Patients
>5 years
post-CABG
(n 5 916)
Time CABG-
SPECT
0.06 – –
Age 0.03 0.03 –
SDS 0.04 – 0.04
NRS 0.0001 0.007 0.0001
CABG 5 coronary artery bypass grafting; NRS 5 number of nonreversible segments;
SDS 5 summed difference score; SPECT 5 single-photon emission computed
tomography.
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multivessel perfusion defects, and increased lung thallium
uptake were significant independent predictors of events.
Lauer et al. (23) demonstrated that even in asymptomatic
patients on average seven years post-CABG, thallium-
perfusion defects were independent predictors of subsequent
death or MI. Their calculated annual all-cause mortality
rates of 3% versus 1% in patients with and without thallium-
perfusion defect, respectively, are discretely higher than our
reported CD rate. In the only prognostic study to date
regarding MPS early (2 years) post-CABG, SSS was the
strongest independent predictor for total mortality (24a).
Their calculated annual event rate of 1.1% is comparable to
ours of 1.3% for patients #5 years post-CABG.
Implications on follow-up strategies in patients post-
CABG. As shown in Figure 6, based on our results,
asymptomatic patients #5 years post-CABG have a low
CD rate and would not benefit from routine nuclear testing.
Symptomatic patients #5 years post-CABG benefit from
nuclear testing because the assessment of the extent and
severity of ischemia provided can help guide appropriate
therapy. Our findings suggest, however, that patients .5
years post-CABG would benefit from MPS irrespective of
symptoms (i.e., even when asymptomatic). Patients who
have normal scans have a low risk of CD and would, in
general, not need catheterization. Patients with an abnormal
scan can be further stratified by infarct size (NRS) or LVEF.
If .20% of the myocardium is infarcted (NRS .4 or an
estimated EF ,45%), patients are at high risk for CD (18)
regardless of the presence of ischemia. These patients may
benefit from viability assessment. If there is evidence of a
small infarct (NRS #4 or an estimated LVEF $45%),
patients can be further stratified by the extent of ischemia
(SDS). If there is no ischemia or mild ischemia (SDS #6)
the annual CD rate is low; such patients could be followed
conservatively. If there is moderate to severe ischemia (SDS
.6), patients have at least a moderate risk of CD and may
benefit from catheterization. Current AHA/ACC clinical
guidelines argue against routine testing of asymptomatic
patients but do allow for “assessment of selected symptom-
free patients” (25).
The question of when to retest patients who have been
tested and subsequently treated medically is a much more
complex issue that would require a more robust patient
population than the one presently being examined to address
adequately this important aspect of patient management.
Study limitations. Because patients tested in our labora-
tory underwent CABG at various hospitals, we are not able
to provide data about the surgical procedure (i.e., how many
bypasses per patient were implanted; how many venous
and/or arterial conduits were used).
Because gated LVEF SPECT was not available in all
patients in this study, we used NRS to substitute for LVEF.
Substituting gated LVEF for NRS would probably add
incremental prognostic value in patients post-CABG and
Figure 3. Early catheterization rates as a function of SSS in patients #5 and .5 years post-CABG (n 5 1,707). *Statistically significant increase as a
function of SSS (p , 0.001). CABG 5 coronary artery bypass graft surgery; SSS 5 summed stress score.
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allow a risk-stratification management based on the inter-
play of LVEF and ischemia (SDS) as it has been shown for
a general population by Lewin et al. (26). This assumption
is supported by a study by Borges-Neto et al. (27), who have
reported the long-term follow-up of 182 patients undergo-
ing exercise radionuclide angiography and coronary angiog-
raphy ,3 years post-CABG. In their study, which did not
include perfusion data, the exercise LVEF was the strongest
predictor of CD, contributing beyond clinical and catheter-
ization data.
Quantitative analysis was not performed in the current
patient group because it was not in operation on all of our
computer systems at the time of the SPECT studies. A
semiquantitative visual analysis was utilized, similar to that
which was the basis for the quantitative analysis program
developed by Cedars-Sinai Medical Center and Emory
University. These prognostic results correlate strongly with
those of quantitative analysis (28).
Conclusions. Dual isotope MPS in patients post-CABG
is strongly predictive of subsequent CD and adds incremen-
tal value over clinical and treadmill test information. Our
data suggest that symptomatic patients #5 years and all
Figure 4. Global chi-square values with respect to prescan information and nuclear variables (n 5 1,544). *Significant increase of chi-square (p , 0.001).
Figure 5. Global chi-square values with respect to clinical, treadmill, and nuclear variables (n 5 703). *,# Significant increase of chi-square (p , 0.05).
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patients .5 years post-CABG may benefit from testing.
However, this may not be true for those patients who are
asymptomatic within the first 5 years post-CABG.
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